I2906

Antimycobacterial and cytotoxic agent (mycobacterium tuberculosis) CAS# 331963-29-2

I2906

2D Structure

Catalog No. BCC1637----Order now to get a substantial discount!

Product Name & Size Price Stock
I2906: 5mg $12 In Stock
I2906: 10mg Please Inquire In Stock
I2906: 20mg Please Inquire Please Inquire
I2906: 50mg Please Inquire Please Inquire
I2906: 100mg Please Inquire Please Inquire
I2906: 200mg Please Inquire Please Inquire
I2906: 500mg Please Inquire Please Inquire
I2906: 1000mg Please Inquire Please Inquire
Related Products
  • I-BET-762

    Catalog No.:BCC4474
    CAS No.:1260907-17-2
  • MS436

    Catalog No.:BCC4037
    CAS No.:1395084-25-9
  • PFI-1 (PF-6405761)

    Catalog No.:BCC2225
    CAS No.:1403764-72-6
  • SGC-CBP30

    Catalog No.:BCC2419
    CAS No.:1613695-14-9
  • Bromosporine

    Catalog No.:BCC2226
    CAS No.:1619994-69-2
  • OTX-015

    Catalog No.:BCC1829
    CAS No.:202590-98-5

Quality Control of I2906

3D structure

Package In Stock

I2906

Number of papers citing our products

Chemical Properties of I2906

Cas No. 331963-29-2 SDF Download SDF
PubChem ID 54679506 Appearance Powder
Formula C25H37N3O4 M.Wt 443.58
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in DMSO
Chemical Name 1-ethyl-4-hydroxy-2-oxo-N'-tridecanoylquinoline-3-carbohydrazide
SMILES CCCCCCCCCCCCC(=O)NNC(=O)C1=C(C2=CC=CC=C2N(C1=O)CC)O
Standard InChIKey WIEYSVJHCLJOJT-UHFFFAOYSA-N
Standard InChI InChI=1S/C25H37N3O4/c1-3-5-6-7-8-9-10-11-12-13-18-21(29)26-27-24(31)22-23(30)19-16-14-15-17-20(19)28(4-2)25(22)32/h14-17,30H,3-13,18H2,1-2H3,(H,26,29)(H,27,31)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of I2906

DescriptionI2906 showed antimycobacterial and cytotoxic activity against mycobacterium tuberculosis. IC50 Value: Target: Antibacterial Under in vitro conditions, I2906 showed excellent antimycobacterial activities and low cytotoxicity. In a murine model infected with M. tuberculosis H37Rv, the reductions on bacterial loads of both lungs and spleen were statistically significant (p < 0.05) between I2906-treated mice and untreated controls after 4 weeks. Further, the colony-forming unit counts in the lungs were dramatically lower (p < 0.05) than that of isoniazid-treated mice by the addition of I2906 after 8 weeks. Moreover, survival rate was increased by I2906 treatment. For multidrug-resistant strain infection, bacterial counts were reduced significantly in the lungs and spleen due to I2906 treatment in comparison with data from untreated controls (p < 0.05).

References:
[1]. Lu, Jingning; Yue, Jun; Wu, Jing et al. In vitro and in vivo Activities of a New Lead Compound I2906 against Mycobacterium tuberculosis. Pharmacology (2010), 85(6), 365-371.

I2906 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

I2906 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of I2906

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.2544 mL 11.2719 mL 22.5438 mL 45.0877 mL 56.3596 mL
5 mM 0.4509 mL 2.2544 mL 4.5088 mL 9.0175 mL 11.2719 mL
10 mM 0.2254 mL 1.1272 mL 2.2544 mL 4.5088 mL 5.636 mL
50 mM 0.0451 mL 0.2254 mL 0.4509 mL 0.9018 mL 1.1272 mL
100 mM 0.0225 mL 0.1127 mL 0.2254 mL 0.4509 mL 0.5636 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on I2906

I2906 showed antimycobacterial and cytotoxic activity against Mycobacterium tuberculosis and alone or in combination with isoniazid reduced bacterial count in lung and spleen of mouse model of multidrug resistant M. tuberculosis infection.

Featured Products
New Products
 

References on I2906

In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.[Pubmed:20530976]

Pharmacology. 2010;85(6):365-71.

BACKGROUND: Due to the long duration of treatment and the emergence of multidrug-resistant strains, new antitubercular agents are urgently needed. I2906, as a novel lead, was screened and tested for efficacy in vitro and in vivo. METHODS: To determine the efficacy of I2906,the minimum inhibitory concentrations against Mycobacterium tuberculosis and cytotoxicity were tested, and its in vivo activities were assessed by administering it to mice infected with M. tuberculosis H37Rv or multidrug-resistant strain. RESULTS: Under in vitro conditions, I2906 showed excellent antimycobacterial activities and low cytotoxicity. In a murine model infected with M. tuberculosis H37Rv, the reductions on bacterial loads of both lungs and spleen were statistically significant (p < 0.05) between I2906-treated mice and untreated controls after 4 weeks. Further, the colony-forming unit counts in the lungs were dramatically lower (p < 0.05) than that of isoniazid-treated mice by the addition of I2906 after 8 weeks. Moreover, survival rate was increased by I2906 treatment. For multidrug-resistant strain infection, bacterial counts were reduced significantly in the lungs and spleen due to I2906 treatment in comparison with data from untreated controls (p < 0.05). CONCLUSIONS: I2906 displayed potential antimicrobial activities against M. tuberculosis H37Rv and drug-resistant strains in vitro and in vivo, and could improve efficacy of isoniazid in vivo.

Description

I2906 showed antimycobacterial and cytotoxic activity against mycobacterium tuberculosis.

Keywords:

I2906,331963-29-2,Natural Products,Antibiotic, buy I2906 , I2906 supplier , purchase I2906 , I2906 cost , I2906 manufacturer , order I2906 , high purity I2906

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: